Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.66% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.55% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Communication Services | 10.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Mercer International
MERC
$32.3M
| $4.62M | ﹤0.01% |
398,617
+11,624
| +3% | +$135K |
|
|
SURF
2952
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $4.61M | ﹤0.01% |
609,257
+116,236
| +24% | +$744K |
|
2953
Flexsteel Industries
FLXS
$301M
| $4.59M | ﹤0.01% |
148,519
-1,021
| -0.7% | -$36.4K |
|
|
MRLN
2954
DELISTED
Marlin Business Services Corp
MRLN
| $4.59M | ﹤0.01% |
206,340
-1,941
| -0.9% | -$43.6K |
|
|
CCRD
2955
DELISTED
CoreCard
CCRD
| $4.58M | ﹤0.01% |
112,900
-1,279
| -1% | -$45.5K |
|
2956
Janux Therapeutics
JANX
$978M
| $4.58M | ﹤0.01% |
211,880
+189,863
| +862% | +$5.46M |
|
|
JNCE
2957
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $4.57M | ﹤0.01% |
614,430
+84,915
| +16% | +$526K |
|
2958
Clear Secure
YOU
$4.7B
| $4.56M | ﹤0.01% |
+111,204
| New | +$5.2M |
|
2959
KRONOS Worldwide
KRO
$905M
| $4.56M | ﹤0.01% |
367,369
-746
| -0.2% | -$9.87K |
|
2960
Zevra Therapeutics
ZVRA
$664M
| $4.56M | ﹤0.01% |
488,732
+15,878
| +3% | +$160K |
|
2961
Diageo
DEO
$52.8B
| $4.56M | ﹤0.01% |
23,613
+1,910
| +9% | +$370K |
|
|
IHC
2962
DELISTED
Independence Holding Company
IHC
| $4.55M | ﹤0.01% |
91,816
+881
| +1% | +$40.5K |
|
2963
Northrim BanCorp
NRIM
$599M
| $4.55M | ﹤0.01% |
427,772
-3,024
| -0.7% | -$31.2K |
|
|
YELL
2964
DELISTED
Yellow Corporation Common Stock
YELL
| $4.54M | ﹤0.01% |
803,895
-25,199
| -3% | -$146K |
|
|
SCWX
2965
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $4.53M | ﹤0.01% |
228,031
+36,168
| +19% | +$748K |
|
|
GPX
2966
DELISTED
GP Strategies Corp.
GPX
| $4.5M | ﹤0.01% |
217,679
+456
| +0.2% | +$9.04K |
|
|
NOAH
2967
Noah Holdings
NOAH
$588M
| $4.48M | ﹤0.01% |
121,704
+5,157
| +4% | +$204K |
|
2968
Fresenius Medical Care
FMS
$12.6B
| $4.47M | ﹤0.01% |
127,925
+5,372
| +4% | +$210K |
|
2969
Neurogene
NGNE
$740M
| $4.47M | ﹤0.01% |
30,891
+1,760
| +6% | +$269K |
|
2970
Aterian
ATER
$5.26M
| $4.46M | ﹤0.01% |
34,354
+11,264
| +49% | +$1.25M |
|
2971
Tonix Pharmaceuticals
TNXP
$214M
| $4.46M | ﹤0.01% |
12
+3
| +33% | +$1.46M |
|
2972
Tenaya Therapeutics
TNYA
$164M
| $4.46M | ﹤0.01% |
+215,963
| New | +$4.64M |
|
|
BZUN
2973
Baozun
BZUN
$164M
| $4.45M | ﹤0.01% |
255,635
+15,675
| +7% | +$386K |
|
|
DAWN
2974
DELISTED
Day One Biopharmaceuticals
DAWN
| $4.43M | ﹤0.01% |
186,627
+151,692
| +434% | +$3.64M |
|
2975
Beam Global
BEEM
$25.5M
| $4.43M | ﹤0.01% |
161,712
+27,723
| +21% | +$824K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.